Change search
ReferencesLink to record
Permanent link

Direct link
Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment - Pooled Analysis of Phase II Trials
Show others and affiliations
2011 (English)Conference paper (Refereed)
Place, publisher, year, edition, pages
Oxford: Pergamon , 2011. Vol. 47, S528-S529 p.
, European Journal of Cancer, ISSN 0959-8049 ; Vol. 47 Suppl. 1
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-49259DOI: 10.1016/S0959-8049(11)72092-5ISI: 000295752801818OAI: diva2:455291
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, September 23-27 2011
Available from: 2011-11-09 Created: 2011-11-04 Last updated: 2011-11-14Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Boman, Kurt
By organisation
Department of Public Health and Clinical Medicine
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 35 hits
ReferencesLink to record
Permanent link

Direct link